These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21516014)

  • 1. Selective IgM deficiency in CD30+ cutaneous lymphoproliferative disorder.
    Saini S; Dettore AJ; Bhambhani KJ; Buck S; Poulik J; Savaşan S
    J Pediatr Hematol Oncol; 2011 May; 33(4):e156-9. PubMed ID: 21516014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyogenic variant of primary cutaneous anaplastic large-cell lymphoma: a lymphoproliferative disorder with a predilection for the immunocompromized and the young.
    Papalas JA; Van Mater D; Wang E
    Am J Dermatopathol; 2010 Dec; 32(8):821-7. PubMed ID: 20881832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
    Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
    Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cutaneous anaplastic large-cell lymphoma.
    Newlove T; Loyd A; Patel R; Jelinek J; Latkowski JA
    Dermatol Online J; 2010 Nov; 16(11):2. PubMed ID: 21163153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained response of primary cutaneous CD30 positive anaplastic large cell lymphoma to bexarotene and photopheresis.
    Sheehy O; Catherwood M; Pettengell R; Morris TC
    Leuk Lymphoma; 2009 Aug; 50(8):1389-91. PubMed ID: 19544141
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of a Phase II Trial of Brentuximab Vedotin for CD30+ Cutaneous T-Cell Lymphoma and Lymphomatoid Papulosis.
    Duvic M; Tetzlaff MT; Gangar P; Clos AL; Sui D; Talpur R
    J Clin Oncol; 2015 Nov; 33(32):3759-65. PubMed ID: 26261247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intralymphatic Spread Is a Common Finding in Cutaneous CD30+ Lymphoproliferative Disorders.
    Ferrara G; Ena L; Cota C; Cerroni L
    Am J Surg Pathol; 2015 Nov; 39(11):1511-7. PubMed ID: 26371781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases.
    Kong YY; Dai B; Kong JC; Lu HF; Shi DR
    Histopathology; 2009 Aug; 55(2):189-96. PubMed ID: 19694826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of mistletoe for CD30+ cutaneous lymphoproliferative disorder/lymphomatoid papulosis.
    Seifert G; Tautz C; Seeger K; Henze G; Laengler A
    J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):558-60. PubMed ID: 17374000
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary cutaneous CD30 positive anaplastic large cell lymphoma in an adolescent.
    Vaid R; Cohen B
    Pediatr Dermatol; 2009; 26(6):721-4. PubMed ID: 20199449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anaplastic large-cell T-cell lymphoma.
    Stein JA; Soldano AC; Latkowski JA
    Dermatol Online J; 2008 May; 14(5):15. PubMed ID: 18627751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of primary cutaneous CD30+ anaplastic large-cell lymphoma with radiation therapy.
    Yu JB; McNiff JM; Lund MW; Wilson LD
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1542-5. PubMed ID: 18037577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous CD30+ anaplastic large-cell lymphoma with generalized skin involvement and involvement of one peripheral lymph node, successfully treated with low-dose oral etoposide.
    Yamane N; Kato N; Nishimura M; Ito M; Yanagi T; Osawa R
    Clin Exp Dermatol; 2009 Jul; 34(5):e56-9. PubMed ID: 19438576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neutrophil-rich, anaplastic CD30+ T cell lymphoma in conjunction with lymphomatoid papulosis].
    Slotosch CM; Hörster S; Hertl M; Schultz E
    Hautarzt; 2010 Jun; 61(6):511-3. PubMed ID: 19536511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of expression of 5-hydroxymethylcytosine in CD30-positive cutaneous lymphoproliferative disorders.
    De Souza A; Tinguely M; Pfaltz M; Burghart DR; Kempf W
    J Cutan Pathol; 2014 Dec; 41(12):901-6. PubMed ID: 25353265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secondary ALK negative anaplastic large cell lymphoma in a patient with lymphomatoid papulosis of 40 years duration.
    Marschalkó M; Eros N; Holló P; Hársing J; Bottlik G; Bátai A; Csukly Z; Masszi T; Szentirmai Z; Fodor J; Kárpáti S; Matolcsy A; Csomor J
    Am J Dermatopathol; 2010 Oct; 32(7):708-12. PubMed ID: 20644462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of multifocal primary cutaneous CD30 anaplastic large cell lymphoma.
    Shehan JM; Kalaaji AN; Markovic SN; Ahmed I
    J Am Acad Dermatol; 2004 Jul; 51(1):103-10. PubMed ID: 15243534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous CD30+ T-cell lymphoproliferative disorder presenting as paraphimosis: a case report and review of the literature.
    McNab PM; Jukic DM; Mills O; Browarsky I
    Dermatol Online J; 2011 Jul; 17(7):3. PubMed ID: 21810388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary cutaneous CD30 positive anaplastic large cell lymphoma--report of a case treated with bexarotene.
    Oliveira A; Fernandes I; Alves R; Lima M; Selores M
    Leuk Res; 2011 Nov; 35(11):e190-2. PubMed ID: 21764128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.